We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Study May Help Sponsors Identify Serious Drug Reactions Sooner
FDA Study May Help Sponsors Identify Serious Drug Reactions Sooner
May 25, 2012
CDER’s discovery of an autoimmune mechanism that leads to serious drug-induced adverse reactions in some patients taking HIV drug Ziagen could give drugmakers new methods to more quickly identify a drugs’ potential to cause severe reactions.